Gufic Biosciences to grab a major share of Rs. 3,000 crore lyophilized antibacterial market

The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients

Proxygen and Merck collaborates to develop molecular glue degraders

The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.

FDA publishes ANP’s polymeric drug excipient DMF

The DMF#36513 demonstrates ANP’s success in the development of its “Plug and Play” drug delivery platform.

AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK

AstraZeneca also played a critical role in the global response to COVID-19.

Indian pharma market to grow at a CAGR of 12.3% to US$130 bn

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030

Ovensa and Celanese to collaborate to advance precision drug delivery

ENTOD Pharmaceuticals gets DCGI nod to carry out the phase 3 trials of 0.05% atropine eye drops

Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children

USFDA accepts dupilumab for priority review in adults with prurigo nodularis

Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved

Thyrocare unveils new brand identity

New logo reflects Thyrocare’s transformation since 1996 to its current leading position at the cutting edge of Diagnostic services